2023 International Congress Archives - Page 82 of 186

p.Gln257Profs*27 mutation in progranulin gene in a patient with corticobasal syndrome – the importance of family history

S. Marques, A. Ferreira, M. Lopes, R. Maré, M. Rodrigues (Braga, Portugal)
Pain and moods disorders as determinants of quality of life in Parkinson

D. Ortiz-Zacarias, I. Estrada-Bellmann, R. Estrella-Silva, J. Trejo-Ayala (Monterrey, Mexico)
Pain and quality of life in cervical dystonia

L. Herrmann, L. Vorbeck, A. Palisi, A. Maurer, S. Lezius, J. Mallwitz, M. Gelderblom, S. Zittel (Hamburg, Germany)
Pain and sleep in Parkinson’s disease

A. Zarnoveanu, S. Diaconu, B. Ciopleias, L. Ungureanu, T. Dragan, B. Ciocanescu, T. Moldovan, C. Falup-Pecurariu (Brasov, Romania)
Pain as a Risk Factor for Developing Depression among Patients with Parkinson’s Disease: A Systematic Review of 1426 patients

S. Mohammed, A. Eldeen (Sohag, Egypt)
Pain in Monogenic Parkinson’s disease: A systematic review

P. Alizadeh, C. Terroba Chambi, V. Bruno (Calgary, Canada)
Pain in people with multiple system atrophy

N. Campese, B. Calio´, F. Leys, L. Kaltenbach, G. Göbel, J. Wanschitz, A. Schlager, L. Zamarian, K. Bannister, R. Chaudhuri, A. Schrag, R. Granata, S. Kiechl, W. Poewe, K. Seppi, G. Wenning, A. Fanciulli (Innsbruck, Austria)
Pain Phenomenon in Parkinson Disease

R. Pinzon (Yogyakarta, Indonesia)
Pain reduction in adults with cervical dystonia and moderate or severe baseline pain following repeated injections of incobotulinumtoxinA: an analysis of pooled data from phase 3 and 4 studies

A. Albanese, J. Wissel, W. Jost, A. Castagna, M. Althaus, G. Comes, A. Scheschonka, M. Vacchelli, H. Jinnah (Rozzano, Italy)
Palliative Care in Parkinson: a family caregiver’s view. A PD-PAL Consortium initiative.

D. Trivedi, M. Qamar, V. Leta, M. Meinders, C. Münte, M. Groot, A. Antonini, M. Garon, K. Ray Chaudhuri (London, United Kingdom)
Pallidal activity as a driving force of choreic movements

T. Hashimoto, T. Goto, K. Yoshida, L. Johnson, C. Hendrix, J. Vitek (Matsumoto, Japan)
Pallidal DBS improves myoclonus in 2 patients with post-hypoxic myoclonus

L. Pan, A. Mogilner, S. Frucht (New York, USA)
Pallidal or subthalamic DBS for advanced Parkinson’s disease in the era of high-resolution MRI

A. Gamaleya, S. Asriants, A. Poddubskaya, A. Dekopov, A. Tomskiy (Moscow, Russian Federation)
Paraneoplastic cerebellar degeneration due to an anti-SOX 1 antibody manifesting as head tremors, without evidence of underlying malignancy

K. Sai Krishna, F. Mustafa, R K. Singh, A. Das, B. Mishra, A. Elavarsi, D. Vibha, M. Tripathy, S. Gaikwad (NEW DELHI, India)
Pareidolias and color discrimination deficits differently correlate with cognitive dysfunction in prodromal Lewy body disease

S. Kim, JH. Choi, KA. Woo, JY. Joo, HJ. Chang, B. Jeon, JY. Lee (Seoul, Republic of Korea)
Parkin Coregulates Glutathione Metabolism in Adult Brain to Contribute to Redox Homeostasis

D. El Kodsi, J. Tokarew, R. Sengupta, A. Chatterji, M. Takanashi, N. Hattori, J. Tomlinson (Ottawa, Canada)
Parkinson disease patient’s awareness of hyperkinetic movements

W. Chouhani, S. Barua, L. Elansari, T. Hatfield, R. Buesa, J. Friedman, U. Akbar (Fez, Morocco)
parkinson’s disease and coffee: is high consumption a protective factor or aversion to coffee taste a risk factor?

G. Procópio, C. Lobo, H. Dourado, MA. Silveira, AE. Lima, I. Oliveira, L. de Almeida, G. Valença (Salvador, Brazil)
Parkinson’s disease and human gut microbiota in an Egyptian population: a pilot study

S. Hashish, M. Hirose, A. Moustafa, A. Shalash, S. Ibrahim, M. Salama (Cairo, Egypt)
Parkinson’s disease and physiotherapy: perspectives in functional health education and innovation in digital media

S. Souza, A. Silva, V. Israel (CURIIBA, Brazil)
Parkinson’s disease and Spatiotemporal gait parameters: A Narrative Review of Effect of Climate Changes as a Mediating Effect

T. Adeniji, O. Olagbegi, T. Nadasan (Durban, South Africa)
Parkinson’s disease-associated psychosis in a Brazilian sample: worse cognitive outcomes, higher LEDD and longer disease duration.

H. Dourado, C. Lobo, G. Procópio, AE. Lima, MA. Silveira, L. de Almeida, IJ. Oliveira, G. Valença (Salvador, Brazil)
Parkinson’s disease: cardiorespiratory fitness, respiratory muscle strength and lung capacity after a high-intensity Aquatic Physiotherapeutic Exercise Program (APEP/PEFA)

L. Paladini, T. Christinelli, G. Leveck, V. Israel (CURITIBA, Brazil)
Parkinson’s Team Training is beneficial for new and established PD Centers

E. Pollard, K. Lyons, D. Beran, C. Hunter, H. Cianci, E. Book (New York, USA)
Parkinson’s disease (PD) progression is associated with past exposure to organic contaminants in water at Marine Corps Base Camp Lejeune

S. Goldman, F. Weaver, B. Gonzalez, K. Stroupe, L. Cao, K. Colletta, E. Brown, C. Tanner (San Francisco, USA)
Parkinson’s disease and Charcot-Marie-Tooth type 2: coincidental or causal?

G. Prado-Miranda, S. Bansal, S. Sharma, M. Jog (London, Canada)
Parkinson’s Disease and Chronic Inflammatory Demyelinating Polyneuropathy: Broadening the Clinical Spectrum of VCP Mutations?

E. Contaldi, L. Magistrelli, R. Cantello, S. Gallo, F. Vignaroli (Novara, Italy)
Parkinson’s Disease Hospital Optimization Project

B. Valdovinos, K. Amodeo, E. Kanouse, A. Chesire, J. Lowell, M. Braun, N. Chunga, D. Ruebeck, A. Macikowski, V. Basic, M. Deweese, E. Hufziger, J. Hayes, A. Skuse, I. Richard (Rochester, USA)
Parkinson’s disease in patients with Gaucher’s disease – causation or association?

B. Pandey (Tirupati, India)
Parkinson’s disease management in the community

L. Ambrosio, MV. Navarta, D. Kunkel, A. Pedraz-Marcos, A. Palmar-Santos, A. Haahr, LB. Vester, LK. Bragstad, TL. Nielsen, NB. Kruse, EG. Hjelle, SB. Haavaag, MC. Portillo (Southampton, United Kingdom)
Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest): Development and Pilot Study of a Questionnaire for Stigma in Patients with Idiopathic Parkinson’s Disease

V. Stopic, S. Jost, JC. Baldermann, JN. Petry-Schmelzer, G. Fink, T. Dembek, H. Dafsari, J. Kessler, M. Barbe, A. Sauerbier (Cologne, Germany)
Parkinson’s disease-specific cortical atrophy as an independent contributor to motor symptom in Parkinson’s disease

SW. Kang, HS. Yoo, CL. Lyoo (Seoul, Republic of Korea)
Parkinson’s Progression Markers Initiative (PPMI) prioritizes enrollment of individuals from diverse and underrepresented populations

R. Dobkin, M. Kutler, A. O'Grady, C. Kelliher, K. Greenwood, M. Kuhl, S. Fong, S. Mantri (Piscataway, USA)
Parkinson’s Progression Markers Initiative (PPMI): Defining PD biology to accelerate PD therapeutics

B. Mcmahon, A. Siderowf, T. Simuni, C. Tanner, B. Mollenhauer, C. Coffey, D. Galasko, K. Posten, L. Chahine, R. Dobkin, T. Froud, K. Kieburtz, D. Weintraub, K. Merchant, M. Frasier, T. Sherer, S. Chowdhury, E. Brown, R. Alcalay, A. Videnovic, K. Fabrizio, E. Flagg, K. Marek (New Haven, USA)
Parkinsonian tremor secondary to Sinking flap syndrome – An atypical presentation

R. Kota, K. Garg, M. Singh, R. Rajan (NEW DELHI, India)
Parkinsonism and dilated ventricles: not all hydrocephalus is normal-pressure

D. Tang, J. Vijayan, CH. Tan, SF. Woo, JH. Tan (Singapore, Singapore)
Parkinsonism in sjogren disease

G. Wechtati, H. Derbali, I. Bedoui, M. Yedaes, M. Messelmani, M. Mansour, J. Zaouali, R. Mrissa (Ben Arous, Tunisia)
PARKinSOUND: Impact of participation in an orchestra in patients with Parkinson’s disease

S. Marques, S. Lopes, A. Ferreira, A. Silva, G. Carneiro, S. Varanda, P. Santos, A. Goios, M. Rodrigues (Braga, Portugal)
ParkProReakt Study Protocol – A randomized controlled trial to evaluate a proactive approach to health care in Parkinson’s disease

M. van Munster, J. Stümpel, N. Altschuck, L. Kerkemeyer, I. Wellach, D. Becker, M. Geraedts, D. Pedrosa (Marburg, Germany)
Paroxysmal Kinesigenic Dyskinesia caused by a novel missense variant in NBEA

M. Hull, J. Fatih, H. Du, D. Pehlivan, J. Posey, J. Lupski, D. Calame (Houston, USA)
PASADENA 1-year open-label extension

G. Pagano, A. Reyes, A. Monnet, M. Martinec, N. Shariati, T. Simuni, K. Marek, R. Postuma, N. Pavese, F. Stocchi, K. Taylor, H. Svoboda, P. Fontoura, G. Kerchner, R. Doody, A. Bonni, T. Nikolcheva (Basel, Switzerland)
Path To Prevention (P2P) Therapeutics Platform Trial in Biomarker Defined Prodromal Parkinson’s Disease: Study Design

C. Coffey, A. Siderowf, C. Tanner, K. Marek, M. Brumm, T. Simuni, P. Investigators, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, B. Saville, C. Allen-Savietta, B. Wendelberger, A. Crawford, K. Fabrizio ()
Pathological findings in a case of DJ-1 early onset Parkinson’s disease

M. Schoenberg, D. Narendra, L. Kenyon, TW. Liang (Philadelphia, USA)
Pathological neuronal Oscillations in an animal model of Rapid-Onset Dystonia-Parkinsonism

M. Möller, J. Nieweler, M. Bähr, C. Van-Riesen (Göttingen, Germany)
Patient characteristics and real-world use of botulinum toxins for treatment of cervical dystonia and blepharospasm

M. Hast, A. Kong, S. Desai, S. Syed, J. Holmes (Raleigh, USA)
Patient experiences in essential tremor: mapping functional impacts to existing measures using qualitative research

M. Gerbasi, D. Goss, J. Petrillo, M. Nejati, S. Lewis (Cambridge, USA)
Patient perspectives on symptoms and functional impacts to inform a digital assessment of Parkinson’s disease

B. Fehlmann, A. Thomann, E. Davies, J. Twiss, C. Romano, D. Whalley, M. Mayorga, C. Levy, F. Lipsmeier, W. Popp, T. Kustermann, H. Svoboda, T. Nikolcheva, D. Trundell, M. Lindemann, K. Taylor (demuro)
Patients activation in people with Parkinson disease and its relation to personal factors

B. Naamneh Abuelhija, M. Kafri, M. Kestenbaum, S. Giveon, G. Yogev-Seligmann (Haifa, Israel)
Patterned alternating-coloured strips for freezing of gait – Novel solution for a disabling symptom.

M. Matta, N. Sawal, D. Bansal (Chandigarh, India)
Patterns of Parkinson disease mitochondrial brain function indexed by 31P magnetic resonance spectroscopy

F. Lopez, C. Hess, A. Ray, R. O'Connell, A. O'Shea, L. Kenney, A. Ratajska, G. Alexander, A. Woods, M. Okun, D. Bowers (Gainesville, USA)
Patterns of subthalamic synchronized oscillatory activity associated with parkinsonian subtypes

P. Zhuang, M. Hallett, H. Feng, Y. Zhang, J. Li, Y. Hu, Y. Li (Beijing, China)
PD-PRIDE: Healthcare experiences of people identifying as LGBTQ+ with Parkinson disease: A qualitative study preliminary analysis

T. Mcisaac, K. Sutton, P. Kalcic, M. Mussack, H. Shill (Phoenix, USA)
PD-PROP reporting in participants own words shows high burden of cognitive symptoms in early Parkinson Disease (PD)

J. Purks, L. Arbatti, A. Hosamath, A. Amara, K. Anderson, L. Chahine, S. Eberly, D. Kinel, S. Mantri, S. Mathur, D. Oakes, D. Standaert, D. Weintraub, I. Shoulson, C. Marras (Rochester, USA)
PD.ai – Detection of Parkinson’s Disease with gait-based biomarkers using AI techniques

SJS. Rajasekar, A. Stezin (Melmaruvathur, India)
PDQ-39 predicts quality of life improvement following neurostimulation for Parkinson’s disease: Prospective observational study

L. Torrão, M. Rosas, J. Massano, A. Oliveira, C. Chamadoira, M. Rito, J. Guimarães, C. Soares (Póvoa de Varzim, Portugal)
Pediatric Myoclonus-Dystonia misdiagnosed as CASPR2 encephalitis – a diagnostic challenge

L. Dias, R. Pissarra, J. Fonseca, C. Melo, M. Sampaio, R. Sousa (Porto, Portugal)
People with Parkinson’s Disease present compensatory cortical activity patterns during split-belt treadmill walking, regardless of leg or disease side dominance.

F. Hulzinga, P. Pelicioni, N. D'Cruz, V. de Rond, P. Ginis, M. Gilat, A. Nieuwboer (Heverlee
Perception of the subjective visual vertical in subjects with cervical dystonia

I. Reuter (Gießen, Germany)
Performance of commercial EEG wearable for sleep classification in Parkinson disease

D. González, D. Wang, E. Pollet, A. Velarde, S. Horn, J. Ramirez-Castaneda, P. Coss, O. Vaou, J. Wang, C. Li, S. Seshadri, H. Miao, M. Gonzales (Chicago, USA)
Peripheral Synucleinopathy in Essential Tremor Plus Patients with Parkinsonian Features and Normal Dopamine Transporter Imaging

VG. Evidente, T. Levine, D. Evidente, R. Freeman, C. Gibbons (Scottsdale, USA)
Peroperative use of the MDS-UPDRS Motor Section: Agreement between Sitting and Supine position

A. Smid, N. Kremer, S. Lange, I. Mateus Marçal, K. Tamasi, M. van Dijk, T. van Laar, G. Drost (Groningen, Netherlands)
Persistence, Health Care Resource Utilization, and Costs Among OnabotulinumtoxinA-Treated Patients with Cervical Dystonia in the US

K. Dashtipour, D. Charles, M. Sadeghi, M. Heath, A. Rava, J. Liu, H. Sun, Y. Dong, J. Lee (Loma Linda, USA)
PET visualization of α-synuclein pathologies in humans using [18F]C05-05

H. Endo, K. Matsuoka, Y. Kataoka, K. Tagai, K. Hirata, N. Kokubo, A. Orihara, M. Oya, H. Matsumoto, S. Kurose, M. Ichihashi, A. Oyama, S. Kitamura, H. Zhang, C. Seki, K. Takahata, T. Tokuda, M. Ono, Y. Takado, H. Shinotoh, A. Sugiyama, T. Hatano, H. Shimada, K. Kawamura, MR. Zhang, M. Higuchi (Chiba, Japan)
PFBC and dystonia: description of a cohort and peculiar cases

G. Bonato, S. Andretta, C. Bertolin, L. Salviati, M. Carecchio (Padova, Italy)
Pharmacokinetics, Safety and Tolerability of Foslevodopa/Foscarbidopa Following Continuous Subcutaneous Infusion to Arm, Thigh and Flank compared to Abdomen in Parkinson’s Disease Patients

Y. Han, H. Kalluri, A. Jeong, C. Locke, M. Facheris, S. Gupta, M. Rosebraugh (North Chicago, USA)
Pharmacological combinations in early stages of Parkinson’s disease and association with motor complications

A. Lanore, E. Januel, N. Bertille, P. Menon, Y. Rajasegaram, S. Carvalho, LL. Mariani, M. Fabbri, O. Rascol, F. Tubach, Y. de Rycke, JC. Corvol (Paris, France)
Pharmacological Invivo and invitro potential of resveratrol in experimental rat models of Parkinson’s disease

R. Kumar, A. Kanojia (Darbhanga, India)
Phenotype and brain [18F] FDG patterns in patients with freezing of gait as the main clinical feature

C. Espinoza-Vinces, F. Abedrabbo, G. Martí-Andrés, J. Mejía, I. Avilés-Olmos, J. Arbizu, MR. Luquin (Pamplona, Spain)
Phenotypic characterization of 104 patients with Progressive Supranuclear Palsy: A Tertiary care experience from South India

R. Yadav, S. Dey, N. Kamble, V. Holla, R. Mahale, M. Debnath, P. Pal (Bangalore, India)
Phenotypic presentation of essential tremor patients with Rapid eye movement disorder

A. Rekik, A. Nasri, S. Mrabet, A. Atrous, A. Souissi, A. Gharbi, I. Kacem, A. Gargouri, R. Gouider (Tunis, Tunisia)
Physical exercise as a promising option for treating fatigue in Parkinson’s disease? Results of a systematic review and meta-analysis of non-pharmacological interventions

A. Folkerts, J. Nielsen, R. Gollan, A. Lansu, D. Solfronk, I. Monsef, N. Skoetz, K. Zeuner, E. Kalbe (Cologne, Germany)
Pilot study incorporating outcome measures after paediatric deep brain stimulation with patient and carer expectations and satisfaction

J. Barnacoat, S. Mohammad, K. Stewart, J. Lewis, S. Coombes, M-C. Waugh, M. Farrar, K. Alba-Concepcion, B. Owler, N. Mahant, R. Dale, S. Paget (Westmead, Australia)
Pilot study of outpatient rehabilitation of patients with Huntington’s disease in Russia

E. Lysogorskaia, T. Ivanov, M. Gukovskaya, A. Mendalieva, L. Brylev (Moscow, Russian Federation)
Pilot study to investigate the use of monopolar sensing to improve the efficiency of DBS programming in Parkinson’s disease

J. Thompson, S. Ojemann, D. Kramer, E. Radcliffe, L. Hirt, M. Case, A. Becker, C. Zarns, R. Raike, A. Baumgartner, K. Kern (Aurora, USA)
Piloting the Cats-and-Dogs tool as a culture-fair test for sensory processing impairment in Parkinson’s disease

D. Mair, K. Dey, E. Camboe, A. Zirra, R. Weil, D. Gallagher, C. Budu, T. Haque, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)
Pisa syndrome and botulinum toxin injection in paraspinal muscles ipsilateral to the bending side: a pilot study

V. Cenacchi, TMI. Lombardo, G. Bellavita, M. Catalan, V. Tommasini, M. Liccari, G. Mazzon, L. Antonutti, P. Manganotti (Trieste, Italy)
Placebo response in Parkinson’s disease (PD) is predicted by expression levels of a specific brain network

J. Barbero, C. Tang, A. Vo, Y. Ma, S. Peng, B. Brakedal, C. Dölle, N. Brekke, C. Tzoulis, D. Eidelberg (Manhasset, USA)
Plasma biomarkers in iRBD patients serve as potential markers of early PD and motor severity

B. Huxford, C. Simonet-Hernandez, L. Pérez-Carbonell, A. Schrag, R. Dobson, A. Noyce (London, United Kingdom)
Plasma glucosylsphingosine in GBA1 E326K, N370S and L444P mutation carriers with and without Parkinson’s disease

A. Haimovich, J. Agin-Liebes, N. Hatcher, L. Yao, C. Waters, R. Alcalay (New York, USA)
POLR3A-Related Disorders and Response to Deep Brain Stimulation

WY. Yau, C. Ashton, E. Mulroy, T. Foltynie, P. Limousine, J. Vandrovcova, R. Stell, M. Davis, P. Lamont (Perth, Australia)
Polyaromatic hydrocarbons in Ambient Particulate Matter (PM 2.5) mediate neurodegeneration through the olfactory-brain axis in C57BL/6 mice

SR. Panda, VGM. Naidu (Guwahati, India)
Polyneuropathy in Parkinson’s disease: cross-sectional analysis of the Bochum Parkinson Nerve Study cohort

R. Scherbaum, L. Basner, L. Ortmann, J. Steininger, K. Müller, A. Bieber, P. Schülken, J. Motte, A. Fisse, T. Grüter, R. Gold, K. Pitarokoili, L. Tönges (Bochum, Germany)
Population-Scale Long-Read Sequencing to Catalog Structural Variants in Parkinson’s Disease

K. Billingsley (bethesda, USA)
Positive and negative myoclonus monitoring using ambulatory surface EMG and 3D accelerometry

S. Rissanen, A. Sinokki, J. Hyppönen, L. Säisänen, K. Silvennoinen, P. Karjalainen, E. Mervaala, Z. Hadj-Allal, R. Kälviäinen (Kuopio, Finland)
Post encephalitic dystonia-ataxia syndrome

A. Elavarasi, F. Mustafa, A. Garg, M. Tripathi, D. Vibha, R. Singh, B. Mishra (New Delhi, India)
Post stroke Restless Limb Syndrome and its impact on sleep and life quality in patients in Rural Gujarat, India

S. Desai, J. Darji, D. Desai (Anand, India)
Post-Covid parkinsonism: a systematic review of clinical presentations

P. Polverino, S. Lalli, M. Lo Giudice, A. Albanese (Rozzano, Italy)
Post-hypoxic myoclonus after bilateral pallidal stimulation: A case report

S. Shah, J. Jimenez-Shahed (New York, USA)
Post-operative imaging findings in deep brain stimulation

T. Santana, L. Correia Guedes, M. Coelho, S. Reimão, B. Cattoni, H. Carvalho (Almada, Portugal)
Postoperative change of local field potentials of subthalamic nucleus during and after period of microlesion effect of implantation of deep brain stimulation lead.

H. Saiki, T. Nakura, S. Taguchi, S. Miyachi, M. Doyu (Nagakute, Japan)
Posturography as an objective measure of disease progression and prognostication in Progressive Supranuclear Palsy

G. Nuebling, S. Katzdobler, J. Levin, G. Höglinger, S. Lorenzl (Munich, Germany)
Potential genetic link between type I diabetes and Parkinson’s disease.

K. Senkevich, P. Alipour, E. Chernyavskaya, E. Yu, A. Noyce, Z. Gan-Or (Montreal, Canada)
Potential role of Alpha-synuclein levels in Platelets in GBA-related PD

G. Uras, S. Lucas, A. Schapira (London, United Kingdom)
Potential treatment for CMT2S caused by IGHMBP2 cryptic splice variant, with ASO based therapeutic

S. Smieszek, C. Tyner, A. Kaden, C. Johnson, C. Polymeropoulos, G. Birznieks, M. Polymeropoulos (Washington, USA)
Potentially inappropriate medication useage among patients newly diagnosed with dementia with Lewy bodies

K. Wyman-Chick, E. Chrenka, M. Barrett, M. Miller, L. Sargent, J. Kuntz, H. Nguyen, A. Werner, Z. Libert, R. Rossom (St Paul, USA)
POU4F1-related ataxia: phenotyping of a rare genetic ataxia.

D. Sugar, B. Webb, D. Hall (Chicago,, USA)
Practice and outcome variation across Parkinson’s Foundation Centers of Excellence

C. Marras, N. Dahodwala, J. Beck, A. Naito, Z. Meyer, A. Ramirez-Zamora, M. Neault, M. Rose Rafferty, T. Davis, H. Liu (Toronto, Canada)
Practices of neurologists in the management of Parkinson’s disease patients in the Republic of Moldova

L. Rotaru, O. Grosu (Chisinau, Republic of Moldova)
Pre-operative predominance of Tremor versus PIGD scores in drug OFF state predicts motor and non-motor outcomes of STN-DBS for Parkinson’s disease

C. Nagireddy, K. Pillai, S. Joshua, A. Pnair, D. Panikar, M. Chacko, A. Kishore (Kochi, India)
Pre-surgical correlates of QoL (PDQ-39) in a DBS eligible PD population

J. Jimenez-Shahed, A. Berg, J. Kirk, M. York, J. Schwalb, M. Siddiqui, J. Mcinerney (New York, USA)
Predicting ALS progression using remote sensor-based assessments

D. Anderson, A. Keil, D. Amato, M. Merickel, M. Kantartjis, S. Jezewski, S. Johnson, S. Polyak, B. Severson, J. Severson (Horsham, USA)
Predicting clinical response after Gamma Knife thalamotomy in essential tremor

R. Barriol, G. Carey, G. Touzet, L. Defebvre, N. Carrière (Lille, France)
Predicting motor outcome and quality of life after subthalamic DBS for Parkinson’s Disease: the role of standard screening measures and wearable-data

V. Geraedts, J. van Vugt, J. Marinus, R. Kuiper, H. Middelkoop, R. Zutt, N. vd Gaag, C. Hoffmann, L. Dorresteijn, J. van Hilten, MF. Contarino (Leiden, Netherlands)
Prediction of freezing of gait in Parkinson’s disease based on wearable sensors

SY. Ouyang, J. Zhao, SD. Chen (Wuhan, China)
Prediction of postoperative delirium after deep brain stimulation surgery in Parkinson`s disease

M. Astalosch, M. Mousavi, L. Martins Ribeiro, GH. Schneider, H. Stuke, S. Haufe, F. Borchers, C. Spies, J. von Hofen-Hohloch, B. Al-Fatly, G. Ebersbach, C. Franke, A. Kühn, D. Kübler-Weller (Berlin, Germany)
Prediction of turning characteristics parameters into Parkinson’s disease

F. Khobkhun, A. Hirunkitti, T. Prasertsakul (Nakhon Pathom, Thailand)
Predictive model for Identification of device-aided therapy (DAT) Candidates in Parkinson´s Disease (DELIST-PD Study)

E. Freire-Alvarez, I. Legarda Ramirez, R. Garcia-Ramos, F. Carrillo, D. Santos-Garcia, JC. Gomez-Esteban, JC. Martinez-Castrillo, I. Martinez-Torres, CJ. Madrid Navarro, MJ. Perez Navarro, F. Valero Garcia, B. Vives Pastor, L. Muñoz-Delgado, B. Tijero, C. Morata-Martinez, R. Aler, IM. Galvan, F. Escamilla-Sevilla (Elche, Spain)
Predictors of cognitive deficits in patients with idiopathic normal pressure hydrocephalus – a pilot MRI volumetric study

I. Straka, V. Bolekova, K. Cho, M. Jezberova, P. Brandoburova, P. Valkovic, Z. Kosutzka (Bratislava, Slovakia)
Predictors of death in Parkinson’s disease

M. Garon, L. Weis, F. Pistonesi, V. Cianci, N. Cazzola, ML. Nasi, R. Biundo, A. Antonini (padova, Italy)
Preliminary evidence for evolution of myoinositol and N-acteylaspartate as biomarkers of disease severity in early-stage multiple system atrophy

P. Trujillo, J. Iregui, K. Hett, A. Wynn, M. Donahue, C. Wong, D. Stamler, D. Claassen (Nashville, USA)
Preliminary report of cerebellar transcranial focused ultrasound for primary orthostatic tremor

J-F. Nankoo, T. Cortez Grippe, J. Ingratta, S. Mustafa, N. Raies, N. Drummond, G. Darmani, A. Lozano, R. Chen (Toronto, Canada)
Preliminary Report on Neuromelanin-Sensitive MRI Signal change after Allogeneic Bone marrow-derived Mesenchymal Stem Cells therapy: Phase IIa double-blind, randomized controlled trial

J. Suescun, M. Schiess, E. Rodarte, C. Adams, T. Ellmore (Houston, USA)
Preliminary Report on the efficacy of Allogeneic Bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for idiopathic Parkinson’s disease: Phase IIa double-blind, randomized controlled trial.

M. Schiess, J. Suescun, C. Green, E. Tharp, S. Chandra, C. Adams, M. Shahnawaz, E. Rodarte, V. Thyne, T. Ellmore (Houston, USA)
Preliminary Report on the Safety and Tolerability of Allogeneic Bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for Parkinson’s disease: Phase IIa double-blind, randomized controlled trial

J. Suescun, T. Ellmore, C. Adams, V. Thyne, E. Tharp, S. Chandra, C. Green, R. Shastri, J. Saltarrelli, M. Schiess (Houston, USA)
Preliminary results of the validation study of the Shame in Parkinson’s disease (SPARK) Scale

I. Debove, C. Rodriguez-Blazquez, S. Murcia, A. Zenger, MM. Kurtis, E. Cubo, C. Falup-Pecurariu, KR. Chaudhuri, H. Reichman, S. Bostantjopoulou, M. Bereau, V. Fleury, P. Krack (Bern, Switzerland)
Premenstrual worsening of UPDRS motor scale in women affected by Parkinson’s Disease

A. Thomas, D. Calisi, M. de Rosa, P. Ajdinaj, S. Sensi, M. Onodrj (Chieti, Italy)
Premonitory urge in patients with tics and functional tic-like behaviors

N. Szejko, J. Fletcher, D. Martino, T. Pringsheim (Calgary, Canada)
Preoperative Dyskinesia Impacts Postoperative Quality of Life in PD Patients with Subthalamic Deep Brain Stimulation

J. Einhaus, H. Jergas, V. Stopic, C. Hennen, JN. Petry Schmelzer, JC. Baldermann, V. Visser-Vandewalle, MT. Barbe (Cologne, Germany)
Preoperative motor deficits and depressive symptoms predict quality of life in patients with Parkinson’s disease at different time points after surgery for subthalamic stimulation.

C. Semmler (Cologne, Germany)
Preoperative trajectory planning is important to minimize intracerebral hemorrhage after deep brain stimulation, in comparison with ventricle peritoneal shunt.

T. Nakura, S. Taguchi, H. Saiki, S. Miyachi, M. Douyuu (Nagakute, Japan)
Preparing for a clinical trial: a run-in natural history study in POLR3A-associated spastic ataxia with intronic mutations amenable to splice-modulating therapeutic approaches

E. Jung, K. Manibarathi, I. Harting, S. Wolf, A. Aartsma-Rus, W. van Roon-Mom, M. Synofzik, H. Graessner, R. Schüle (Heidelberg, Germany)
Presence of neuropathy in most frequent hereditary cerebellar ataxia SCA1, SCA2 and FRDA in Serbian population

V. Marković, A. Milovanović, N. Mazalica, O. Tamaš, M. Ječmenica Lukić, A. Kačar, S. Perić, M. Svetel, VS. Kostić, NT. Dragašević Mišković (Belgrade, Serbia)
Presenting the Dystonia Pain Classification System (Dystonia-PCS)

C. Listik, E. Listik, F. Rolim, D. Portela, S. Lloret, N. Araújo, P. Carvalho, G. Santos, J. Limongi, F. Cardoso, V. Mylius, F. Brugger, A. Fernandes, E. Barbosa, M. Teixeira, H. Ferraz, S. Camargos, R. Nascimento, M. Cunningham, L. Moriyama, S. Lino, F. Vale, J. Lapa, R. Cury, D. Andrade (Sao Paulo, Brazil)
Prevalence and clinical characteristics of young onset Parkinson’s Disease among Nepalese Population

R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari (Kathmandu, Nepal)
Prevalence and severity of non-motor symptoms in hispanic at-risk population with REM-sleep behavior disorder.

E. Argüelles-González, A. Jorge-de Sarachaga, R. Solís-Vivanco, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)
Prevalence of cardiovascular drugs and oral anticoagulants use among persons with and without Parkinson’s disease

B. Babar (Kuopio, Finland)
Prevalence of cogwheel phenomenon in Parkinson disease

S. Barua, W. Chouhani, A. D’Abreu, J. Friedman, U. Akbar (Providence, USA)
Prevalence of depression and cognitive impairment in a Hungarian Parkinson’s disease Center

EK. Balogh, E. Balogh, A. Mező, M. Bokor (Budapest, Hungary)
Prevalence of multiple system atrophy in Europe: literature review

S. Kaplan (Netanya, Israel)
Prevalence of seizures in patients with Neurodegeneration with Brain Iron Accumulation

D. Kalikavil Puthanveedu, A. Cherian (Thiruvananthapuram, India)
Prevalence of sleep disorders in patients with Parkinson’s disease undergoing screening: a retrospective study.

J. Garza Marichalar, A. Ferrari Aquino, P. Garza Manrique, B. Chávez Luévanos, I. Estrada Bellmann, M. Vidal Tijerina, A. Romo Alanís, F. Patiño López, M. Torrecillas Gordillo (Monterrey, Mexico)
Prevalence of urinary symptoms and its impact on life quality in patients living with parkinson disease in a mexican population

A. Herrera Ruiz, D. Aguila-Godinez, M. Ruiz-Mafud, M. Medrano-Delgado, A. Domínguez-García, E. Santiago-Delacruz, A. Regalado-Mustafá, M. Medina-Pérez, L. Lira-Juarez,, G. Hernández-Armesto, K. Talavera-Lagunas, J. García-Hernández, A. Hernández-Medrano, D. Romero-Teran, A. Alcocer-Salas, G. Cerda Hernández, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)
Prevalence, clinical characteristics, and quality of life of orthostatic tremor and orthostatic myoclonus in Thai patients with Parkinson’s disease: Prospective cross-sectional study

P. Kiatsermsakul, Y. Pitakpatapee, W. Saengphatarachai, K. Boonyapisit, P. Srivanitchapoom (Bangkok, Thailand)
Primary CNS Lymphoma presenting with Hemichorea Hemiballismus.

N. Sharma (Chandigarh, India)
Probiotics for treatment of constipation in Parkinson’s patients: a systematic review and meta-analysis

M. Alsaied, A. Elettreby, A. Abo Elnaga, D. Kamal, G. Alderbi, A. Sharkawy, R. Fareed (Mansoura, Egypt)
Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study

S. Joza, M. Hu, KY. Jung, D. Kunz, D. Arnaldi, JY. Lee, L. Ferini-Strambi, E. Antelmi, F. Sixel-Döring, V. de Cock, J. Montplaisir, M. Lawton, HJ. Kim, F. Bes, P. Mattioli, K. Woo, S. Marelli, G. Plazzi, B. Mollenhauer, A. Pelletier, JS. Sunwoo, N. Girtler, C. Trenkwalder, JF. Gagnon, R. Postuma (Montreal, Canada)
Prodromal stage early biomarkers in Parkinson’s disease and parkinsonism in Uzbek nationality

DT. Akramova, GS. Rakhimbaeva (Tashkent, Uzbekistan)
Prognostic impact of frontal-lobe clinical bedside signs in progressive supranuclear palsy

I. Ruiz Barrio, A. Horta Barba, S. Martinez Horta, J. Kulisevsky, J. Pagonabarraga (Barcelona, Spain)
Prognostic significance of peripheral neutrophils and lymphocytes in early Parkinson’s disease

JS. Jun, R. Kim (Seoul, Republic of Korea)
Progression of striatocortical dysfunction in Parkinson’s disease: a longitudinal combined PET and fMRI study

K. Steidel, M. Ruppert-Junck, A. Greuel, M. Tahmasian, F. Maier, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, C. Eggers, D. Pedrosa (Marburg, Germany)
Progression of the Clinical Features of Progressive Supranuclear Palsy-Richardson Syndrome in Early and Advanced Stages

T. Xie, C. Liao, L. Golbe (Chicago, USA)
Progressive cortical cerebrovascular reactivity reduction occurs in Parkinson’s disease: a longitudinal study

LR. Jin (Shanghai, China)
Progressive myoclonic epilepsy ataxia syndrome associated with NUS1 gene mutation

R. Vasireddy, M. Bensalem-Owen, Z. Guduru (Lexington, USA)
Progressive myoclonus ataxia and resting tremor in hypoceruloplasminemia

L. Pollini, M. Novelli, F. Nardecchia, K. Bernardi, E. Colacino, F. Pisani, V. Leuzzi, S. Galosi (Rome, Italy)
Progressive Supranuclear Palsy: Review On Diagnostic Aspects Based On A Case

A. Kurniadi (Kabupaten Bekasi, Indonesia)
Pronounced Cervical Dystonia in Ataxia with Vitamin E Deficiency

M. Soares, T. Guimarães, J. Parmera, M. Oliveira, R. Barbosa, F. Kok, E. Barbosa, R. Cury (São Paulo, Brazil)
Proof-of-concept clinical trial: Prevent cognitive decline in GBA-associated Parkinson’s Disease

K. Brockmann, JC. Corvol, A. Difonzo, S. Durrleman, T. Gasser, M. Hu, R. Krüger, I. Liepelt-Scarfone, M. Matarazzo, A. Pilotto, T. Simuni, P. Svenningsson, D. Weintraub, G. Pagano (Tuebingen, Germany)
Proposed model for the delivery of tertiary-care, interdisciplinary tremor evaluations.

D. Roque, V. Krishna, M. Collins, J. Ferrall, N. Sharma (Chapel Hill, USA)
Prospective, Multicenter, International Registry of Deep Brain Stimulation for Dystonia: A Sub-Analysis of Cervical Dystonia Patients

A. Albanese, S. Delvaux, L. Chen, R. Jain, J. Krauss (Milan, Italy)
Protective effect and mechanism of TREM2 in Parkinson’s disease with cognitive impairment

P. Zhang, Y. Zhang (Guanzhou, China)
Protective potential of laughter yoga and clapping exercise on stress level and motor functions in Parkinson’s disease patients with type 2 diabetes

R. Singh, V. Sharma (Delhi, India)
Protein X: a key player in Parkinson’s Disease pathophysiology? – insights from compound screening in gba1 knock-out medaka

E. Nakanishi, T. Taguchi, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)
Proteomic profiles analysis of plasma exosomes and WBC reveals news insights of PD patients classified into H&Y clinical stage

BL. Fadel, N. Woldmar, G. Poralla, J. Fontes, L. Giacomin, M. Figueiredo, J. Evaristo, F. Nogueira, C. Panis, A. Rosso, L. Pizzatti (Rio de Janeiro, Brazil)
PRRT2 paroxysmal dyskinesia mimicking functional motor disorders: a pediatric case.

V. Baglioni, D. Esposito, K. Bernardi, M. Novelli, S. [email protected], V. Leuzzi (Rome, Italy)
Pseudogout Mimicking Stiffness in Parkinson’s Disease: A Case Report

S. Kazanci, M. Afshari, J. Fleisher (Chicago, USA)
Psilocybin therapy for depression and anxiety associated with Parkinson’s disease: a pilot study (NCT04932434)

E. Bradley, K. Sakai, G. Fernandes, C. Ludwig, M. Bock, J. Ostrem, C. Tanner, A. O'Donovan, P. Finley, Z. Busby, A. Mckernan, R. Zuzuarregui, A. Penn, A. Wang, A. Theberge, R. Rosen, J. Woolley (San Francisco, USA)
PSP registry: preliminary cross-sectional results of the first 2 years of recruitment of a multicenter registry and biorepository.

C. Painous, M. Fernandez, M. Soto, A. Cámara, Y. Compta (Barcelona, Catalonia)
PSP-like phenotype triggered by STN DBS in PD: a case report

W-H. Chang, Y-C. Chen, P-L. Chen, P-H. Tu, C-H. Yeh, T-C. Liu, C-S. Lu, C-C. Chen (Taoyuan, Taiwan)
Psychometric properties of the Neuropsychiatric Fluctuations Scale: preliminary results in patients with Parkinson’s disease

C. Rodriguez-Blazquez, I. Debove, S. Murcia, A. Zenger, MM. Kurtis, E. Cubo, C. Falup-Pecurariu, KR. Chaudhuri, H. Reichmann, B. Falkenburger, S. Bostantjopoulou, P. Martinez-Martin, MJ. Forjaz, M. Bereau, P. Krack (Madrid, Spain)
Psychosocial factors impacting participation in a time-intensive deep brain stimulation study of individuals with Parkinson’s disease and dystonia

A. Hahn, S. Cernera, C. Racine, S. Little, P. Starr (San Francisco, USA)
Publication rates and characteristics of clinical trials in deep brain and responsive neurostimulation

M. Chua, A. Warren, J. Rolston (Boston, USA)
Pupil response is impaired in clinically isolated REM Sleep Behavior Disorder and Parkinsons’ Disease

W. Hermann, M. Brandt, T. Sehr, U. Walter, H. Reichmann, A. Storch, T. Ziemssen (Rostock, Germany)
Putting the patient’s voice at the venter: Tracking the impact of botulinum neurotoxin therapy for movement disorders using patient-reported outcomes

S. Samadzadeh, V. Koska, J. Waskönig, PJ. Jouvenal, SGM. Meuth, HH. Hefter, PA. Albrecht (Düsseldorf, Germany)